Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence

被引:67
作者
Cordoba, Juan [1 ,2 ,3 ]
Garcia-Martinez, Rita [1 ,2 ]
Simon-Talero, Macarena [1 ,2 ]
机构
[1] Hosp Univ Vall dHebron, Serv Med Interna Hepatol, Barcelona 08035, Spain
[2] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
[3] Inst Salud Carlos III, CIBERehd, Madrid, Spain
关键词
Metabolic encephalopathy; Hepatic encephalopathy; Liver failure; Cirrhosis complications; Human; CEREBRAL EDEMA; INTRACRANIAL-PRESSURE; BRAIN EDEMA; MAGNETIC-RESONANCE; WATER-INTOXICATION; ORGANIC OSMOLYTES; PROGNOSTIC VALUE; LIVER-DISEASE; CIRRHOSIS; VOLUME;
D O I
10.1007/s11011-010-9172-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyponatremic and hepatic encephalopathy are common causes of metabolic encephalopathy that may coexist in patients with cirrhosis. The clinical picture is common to any metabolic encephalopathy and is characterized by a confusional syndrome that may evolve into coma. Chronic mild or minimal manifestations can be seen in both, but motor symptoms are more common in hepatic encephalopathy. Recent advances show that in addition to clinical manifestations both encephalopathies share some pathogenetic mechanisms. Dysfunction of astrocytes, osmotic changes in the brain and brain edema are present in both situations. Recognition of these abnormalities is important to plan therapy. New drugs that affect brain hydration may be useful for both encephalopathies.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 57 条
[41]   Astrocytic-ammonia interactions in hepatic encephalopathy [J].
Norenberg, MD .
SEMINARS IN LIVER DISEASE, 1996, 16 (03) :245-253
[42]   Minimal hepatic encephalopathy:: diagnosis, clinical significance and recommendations [J].
Ortiz, M ;
Jacas, C ;
Córdoba, J .
JOURNAL OF HEPATOLOGY, 2005, 42 :S45-S53
[43]  
Plum F., 1982, DIAGNOSIS STUPOR COM
[44]   Review article: the burden of hepatic encephalopathy [J].
Poordad, F. F. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 :3-9
[45]   Aquaporin-4 in hepatic encephalopathy [J].
Rao, K. V. Rama ;
Norenberg, M. D. .
METABOLIC BRAIN DISEASE, 2007, 22 (3-4) :265-275
[46]  
Renneboog B., 2006, Am J Med, V119, P71, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]
[47]   Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis [J].
Restuccia, T ;
Gómez-Ansón, B ;
Guevara, M ;
Alessandria, C ;
Torre, A ;
Alayrach, ME ;
Terra, C ;
Martín, M ;
Castellví, M ;
Rami, L ;
Sainz, A ;
Ginès, P ;
Arroyo, V .
HEPATOLOGY, 2004, 39 (06) :1613-1622
[48]   Magnetic resonance imaging measurement of brain edema in patients with liver disease:: resolution after transplantation [J].
Rovira, A ;
Córdoba, J ;
Raguer, N ;
Alonso, J .
CURRENT OPINION IN NEUROLOGY, 2002, 15 (06) :731-737
[49]   Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia [J].
Schrier, Robert W. ;
Gross, Peter ;
Gheorghiade, Mihai ;
Berl, Tomas ;
Verbalis, Joseph G. ;
Czerwiec, Frank S. ;
Orlandi, Cesare .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2099-2112
[50]   Quantitative cerebral water content mapping in hepatic encephalopathy [J].
Shah, N. J. ;
Neeb, H. ;
Kircheis, G. ;
Engels, P. ;
Haeussinger, D. ;
Zilles, K. .
NEUROIMAGE, 2008, 41 (03) :706-717